protocols, the median survival for patients who underwent surgical resection is reported to be around 20 months. Several factors have been identified as predictors for survival as tumor size and differentiation, lymph node ratio and resection margins. Patients and methods: This study included patients who underwent PD for pathologically proven periampullary adencarcinomas at Gastrointestinal Surgery Center, Mansoura University, Egypt in the period between March 2006 and April 2012. Patients were divided into 2 groups; patients who survived less than 5 years and those who survived more than 5 years. Results: During the study period 228 patients underwent PD for periampullary adenocarcinoma. Of those patients, 181 were short-term survivors (< 5 years) and 47 were long -term survivors (> 5 years). The median 5-year survival was 34 months (20 %). Pancreatic adenocarcinoma showed the worst 5-year survival (27 months) while ampullary adenocarcinoma showed the best 5-year survival (54 months). Short-term survivors significantly demonstrated high levels of CA 19-9 (P = 0.04). Regarding the tumor size, the tumor was significantly smaller in size in the longterm survivors group (P < 0.001). R0 resections had better prognosis and survival. Conclusion: Predictors for long-term survival were tumor size less than 2 cm in diameter, negative resection margins and pre-operative CA 19-9 levels of less than 37 U/ml. Nodal status was not found to affect the long-term survival.
EP02C-028 PANCREATIC DUCT LIGATION IN A KRAS MODEL OF PANCREATIC ADENOCARCINOMA REDUCES THE NUMBER AND THE RISK OF APPARITION OF PREMALIGNANT LESIONS OVER TIME F. Burdio 1 , R. Quesada 2 , L. Grande 2 and M. Cáceres 2 1 Surgery, and 2 Hospital del Mar, Spain Introduction: Pancreatic duct ligation (PDL) in murine model has been described as an exocrine pancreatic atrophy-inducing procedure. However, its influence has not been described on premalignant lesions. This study describes the histological changes of premalignant lesions in a transgenic murine PDL model. Methods: Selective ligation of the splenic lobe of the pancreas was performed, including its main pancreatic duct, in Ptf1a-Cre (+/ki); K-ras LSLG12Vgeo (+/ki) mice (PDL-Kras mice).Three experimental groups have been considered: PDL group, controls and shams. We analyzed the presence and number of premalignant lesions (PanIN 1, 2, 3 and Atypical Flat Lesions) in Proximal (PP) and distal (DP) pancreas for each group at different postoperative periods. Results: Controls and shams have a 7 and 9-time increase of risk of presenting PanIN 2, 3 and AFL in their distal pancreas (High Grade Pancreatic lesions -HGPL-), than PDL-Kras mice. Furthermore, PDL-Kras mice have significantly less PanIN 1, 2 and AFL lesions in DP compared to PP. Conclusions: Pancreatic duct ligation in Ptf1a-Cre (+/ki); K-ras LSLG12Vgeo (+/ki) mice induces a decrease in the presence of premalignant lesions in the ligatured distal pancreas. Solid pseudopapillary neoplasm (SPN) of the pancreas has low grade malignant potential and can be cured by complete surgical resection. We herein report the 2 children patients underwent subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) for SPN.
One patient was a 14-year-old girl with manifesting intraperitoneal hemorrhage due to traumatic tumor rupture. The tumor, 5.4cm in diameter, located at the pancreas head. The other patient was a 14-year-old girl with complaining of nausea and diagnosed as having pancreas head tumor measured 3.6 cm in diameter. Both patients underwent EUS-FNA and pathologically diagnosed with SPN, and had surgery a few months after initial diagnosis because they prioritized their school life. The postoperative convalescence was uneventful in both cases. During 3 and 2 years follow-up periods respectively, they are in good health without recurrence.
SPN of the pancreas typically affects young females in their second or third decades, and considered especially rare in children. The most common symptoms are abdominal pain and a palpable mass. Some patients are asymptomatic, and the tumors are detected incidentally as the former case.
Surgical resection offers a long-term survival with 5-year survival rates as high as 95-97%. On the other hand, regardless of its benign pathological features, SPN has a latent ability to recur, including hepatic metastasis, local recurrence, and peritoneal dissemination. Although incidence of lymph node metastasis is rare, some reports indicate a relationship between lymph node positivity and recurrence.
Pancreatic resection and long-term follow-up are considered a reasonable treatment for SPN of the pancreas. Electronic Posters (EP02A-EP02F) e Pancreas S539
